Ampio suspends patient enrollment in its phase 3 study of ampion

Ampio suspends patient enrollment in its phase 3 study of ampion for severe osteoarthritis of the knee and explores other options to complete trial.ampio pharmaceuticals inc - it is possible that covid-19 pandemic may prevent completion of ap-013 trial at this time or at all..ampio pharmaceuticals inc - focusing on investigating potential use of nebulized ampion for treatment of a serious complication of covid-19.
AMPE Ratings Summary
AMPE Quant Ranking